Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

About 61% of women who had COVID-19 experienced hair loss afterward.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Alopecia areata is hard to treat, but new targeted therapies show promise.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Oral prednisolone helps hair regrowth in alopecia areata.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Assessing oral health before chemotherapy is crucial to reduce harmful side effects.

Oral stem cells show promise for tissue repair, but more human trials are needed.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

Oral-derived stem cells can effectively regenerate bone and tissues in dental procedures.